- Home
- PRPH vs PRPO Comparison
PRPH vs PRPO Comparison
Compare PRPH & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- PRPO
- Stock Information
- Founded
- PRPH 1989
- PRPO N/A
- Country
- PRPH United States
- PRPO United States
- Employees
- PRPH N/A
- PRPO N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- PRPH Health Care
- PRPO Industrials
- Exchange
- PRPH Nasdaq
- PRPO Nasdaq
- Market Cap
- PRPH 15.2M
- PRPO 17.1M
- IPO Year
- PRPH 1997
- PRPO N/A
- Fundamental
- Price
- PRPH $0.43
- PRPO $15.75
- Analyst Decision
- PRPH
- PRPO
- Analyst Count
- PRPH 0
- PRPO 0
- Target Price
- PRPH N/A
- PRPO N/A
- AVG Volume (30 Days)
- PRPH 4.1M
- PRPO 16.2K
- Earning Date
- PRPH 08-13-2025
- PRPO 08-12-2025
- Dividend Yield
- PRPH N/A
- PRPO N/A
- EPS Growth
- PRPH N/A
- PRPO N/A
- EPS
- PRPH N/A
- PRPO N/A
- Revenue
- PRPH $5,845,000.00
- PRPO $20,029,000.00
- Revenue This Year
- PRPH $221.82
- PRPO N/A
- Revenue Next Year
- PRPH N/A
- PRPO N/A
- P/E Ratio
- PRPH N/A
- PRPO N/A
- Revenue Growth
- PRPH N/A
- PRPO 26.67
- 52 Week Low
- PRPH $0.22
- PRPO $3.90
- 52 Week High
- PRPH $3.64
- PRPO $16.89
- Technical
- Relative Strength Index (RSI)
- PRPH 62.32
- PRPO 76.66
- Support Level
- PRPH $0.32
- PRPO $10.60
- Resistance Level
- PRPH $0.46
- PRPO $11.70
- Average True Range (ATR)
- PRPH 0.03
- PRPO 0.97
- MACD
- PRPH 0.01
- PRPO 0.45
- Stochastic Oscillator
- PRPH 75.57
- PRPO 81.25
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.